» Articles » PMID: 11533135

Open Probability of Homomeric Murine 5-HT3A Serotonin Receptors Depends on Subunit Occupancy

Overview
Journal J Physiol
Specialty Physiology
Date 2001 Sep 5
PMID 11533135
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

1. The time course of macroscopic current responses of homomeric murine serotonin 5-HT3A receptors was studied in whole cells and excised membrane patches under voltage clamp in response to rapid application of serotonin. 2. Serotonin activated whole cell currents with an EC(50) value for the peak response of 2 microM and a Hill slope of 3.0 (n = 12), suggesting that the binding of at least three agonist molecules is required to open the channel. 3. Homomeric 5-HT3A receptors in excised membrane patches had a slow activation time course (mean +/- S.E.M. 10-90 % rise time 12.5 +/- 1.6 ms; n = 9 patches) for 100 microM serotonin. The apparent activation rate was estimated by fitting an exponential function to the rising phase of responses to supramaximal serotonin to be 136 s(-1). 4. The 5-HT3A receptor response to 100 microM serotonin in outside-out patches (n = 19) and whole cells (n = 41) desensitized with a variable rate that accelerated throughout the experiment. The time course for desensitization was described by two exponential components (for patches tau(slow) 1006 +/- 139 ms, amplitude 31 %; tau(fast) 176 +/- 25 ms, amplitude 69 %). 5. Deactivation of the response following serotonin removal from excised membrane patches (n = 8) and whole cells (n = 29) was described by a dual exponential time course with time constants similar to those for desensitization (for patches tau(slow) 838 +/- 217 ms, 55 % amplitude; tau(fast) 213 +/- 44 ms, 45 % amplitude). 6. In most patches (6 of 8), the deactivation time course in response to a brief 1-5 ms pulse of serotonin was similar to or slower than desensitization. This suggests that the continued presence of agonist can induce desensitization with a similar or more rapid time course than agonist unbinding. The difference between the time course for deactivation and desensitization was voltage independent over the range -100 to -40 mV in patches (n = 4) and -100 to +50 mV in whole cells (n = 4), suggesting desensitization of these receptors in the presence of serotonin does not reflect a voltage-dependent block of the channel by agonist. 7. Simultaneously fitting the macroscopic 5-HT3A receptor responses in patches to submaximal (2 microM) and maximal (100 microM) concentrations of serotonin to a variety of state models suggests that homomeric 5-HT3A receptors require the binding of three agonists to open and possess a peak open probability greater than 0.8. Our modelling also suggests that channel open probability varies with the number of serotonin molecules bound to the receptor, with a reduced open probability for fully liganded receptors. Increasing the desensitization rate constants in this model can generate desensitization that is more rapid than deactivation, as observed in a subpopulation of our patches.

Citing Articles

Markov state models of proton- and pore-dependent activation in a pentameric ligand-gated ion channel.

Bergh C, Heusser S, Howard R, Lindahl E Elife. 2021; 10.

PMID: 34652272 PMC: 8635979. DOI: 10.7554/eLife.68369.


Structure, Function and Physiology of 5-Hydroxytryptamine Receptors Subtype 3.

Gibbs E, Chakrapani S Subcell Biochem. 2020; 96:373-408.

PMID: 33252737 DOI: 10.1007/978-3-030-58971-4_11.


5-HT receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders.

Bhatt S, Devadoss T, Manjula S, Rajangam J Curr Neuropharmacol. 2020; 19(9):1545-1559.

PMID: 33059577 PMC: 8762176. DOI: 10.2174/1570159X18666201015155816.


Orthosteric and Allosteric Activation of Human 5-HTA Receptors.

Rodriguez Araujo N, Fabiani C, Mazzarini Dimarco A, Bouzat C, Corradi J Biophys J. 2020; 119(8):1670-1682.

PMID: 32946769 PMC: 7642218. DOI: 10.1016/j.bpj.2020.08.029.


Tricyclic antidepressant amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells.

Park Y, Myeong S, Kim I, Sung K Korean J Physiol Pharmacol. 2018; 22(5):585-595.

PMID: 30181705 PMC: 6115347. DOI: 10.4196/kjpp.2018.22.5.585.


References
1.
Farthing M . Irritable bowel syndrome: new pharmaceutical approaches to treatment. Baillieres Best Pract Res Clin Gastroenterol. 1999; 13(3):461-71. DOI: 10.1053/bega.1999.0040. View

2.
Perez E . 5-HT3 antiemetic therapy for patients with breast cancer. Breast Cancer Res Treat. 1999; 57(2):207-14. DOI: 10.1023/a:1006233802863. View

3.
Banke T, Bowie D, Lee H, Huganir R, Schousboe A, Traynelis S . Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci. 2000; 20(1):89-102. PMC: 6774102. View

4.
Papke R, Meyer E, Nutter T, Uteshev V . alpha7 receptor-selective agonists and modes of alpha7 receptor activation. Eur J Pharmacol. 2000; 393(1-3):179-95. DOI: 10.1016/s0014-2999(00)00009-1. View

5.
Lobitz N, Gisselmann G, Hatt H, Wetzel C . A single amino-acid in the TM1 domain is an important determinant of the desensitization kinetics of recombinant human and guinea pig alpha-homomeric 5-hydroxytryptamine type 3 receptors. Mol Pharmacol. 2001; 59(4):844-51. DOI: 10.1124/mol.59.4.844. View